Effects of a Metacognitive Smartphone Intervention for Patients with Schizophrenia: A Quasi-Experimental Study (Preprint)
BACKGROUND The COVID-19 pandemic has presented a substantial burden on the global medical system. COVID-19-related restrictions on movement and face-to-face interactions to prevent the spread of infection have increased the risk for patients with schizophrenia being overlooked by medical professionals due to increased demands on staff and facilities. Therefore, application-based treatments and interventions developed for smartphones could provide effective and essential alternatives to traditional face-to-face treatment programs for patients with schizophrenia during the COVID-19 pandemic. OBJECTIVE This study aimed to test the effect of a smartphone app-based metacognitive intervention program on the metacognitive beliefs, psychotic symptoms, and social functioning of patients with schizophrenia. METHODS The study used a quasi-experimental design with a non-equivalent comparison group. Participants were patients with schizophrenia registered with community psychosocial rehabilitation centers. For the experimental group, the app-based intervention was combined with weekly contact mentoring sessions over 10 weeks (20 participants: severe psychotic symptoms and low social functions). The comparison group (24 participants: relatively light psychotic symptoms and good social functions) received only the app-based intervention over 10 weekly sessions. Changes in the Dysfunctional Metacognitive Beliefs (MCQ-30), Psychotic Symptom Rating Scales, Positive and Negative Syndrome Scale, and Personal and Social Performance Scale were assessed at baseline (pre-intervention), post-intervention, and four-week follow-up. Data were collected from November 18, 2020, until July 15, 2021. The data analysis was carried out using IBM SPSS/WIN version 26.0. RESULTS The experimental group showed a significant improvement in the Positive Beliefs about Worries on the MCQ-30, Need for Control (P = .039), and Delusions (P < .001), and the Total Score for positive and negative syndromes, along with a decline in general psychotic symptoms (P = .027) and improved total social function scores (P = .001) over the three assessment periods. CONCLUSIONS Although there were no differences in the measures between the two groups; however, the experimental group showed a tendency toward improved psychotic symptoms and social functioning over time; while the comparison group showed no change over the assessment periods. These findings can provide an empirical basis for using smartphone applications to manage the symptoms of patients with schizophrenia.